Olgu Sunumu
BibTex RIS Kaynak Göster

Markedly elevated lipase as the first manifestation of celiac disease: Case Report

Yıl 2021, Cilt: 3 Sayı: 2, 80 - 84, 29.04.2021
https://doi.org/10.46310/tjim.814732

Öz

Lipase is a hydrolytic enzyme and commonly used for the diagnosis of pancreatitis with amylase. Except for pancreatitis, lipase is elevated in many clinical conditions such as hepatobiliary disorders, bowel diseases, malignancies, renal impairment. Celiac disease (CD) should be considered as one of the causes. In patients with CD, the frequency of pancreatic hyperenzymemia and possible pathophysiological mechanisms are not well studied. To date, several mechanisms explaining pancreatic hyperenzymemia in CD are reported. Malnutrition, disease bowel induced pancreatic dysfunction, autoimmune pancreatic inflammation, and macroenzymemia are the main ones. Herein, we report a patient with newly diagnosed CD, representing markedly elevated serum lipase level with normal amylase.

Destekleyen Kurum

-

Proje Numarası

-

Teşekkür

-

Kaynakça

  • 1. Frulloni L, Patrizi F, Bernardoni L, Cavallini G. Pancreatic hyperenzymemia: Clinical significance and diagnostic approach.JOP. 2005 ;6:536-51.
  • 2. Holmes GK. Non-malignant complications of coeliac disease. Acta Paediatr Suppl. 1996;412:68-75.
  • 3. Carroccio A, Di Prima L, Scalici C, Soresi M, CefalÙ AB, Noto D, et al. Unexplained elevated serum pancreatic enzymes: A reason to suspect celiac disease. Clin Gastroenterol Hepatol. 2006;4:455–9.
  • 4. Hameed AM, Lam VWT, Pleass HC. Significant elevations of serum lipase not caused by pancreatitis: A systematic review. Hpb. 2015;17:99–112.
  • 5. Migliori M, Galassi E, Gullo L. Search for celiac disease in subjects with asymptomatic pancreatic hyperenzymemia. Pancreas. 2011;40:979-81.
  • 6. Freeman HJ. Celiac-associated pancreatic disease. Ann Gastroenterol. 2016;29:241-2.
  • 7. Lauret E, Rodrigo L. Celiac disease and autoimmune-associated conditions. Biomed Res Int. 2013;2013:127589
  • 8. Di Sabatino A, Corazza GR. Coeliac disease. Lancet. 2009;373:1480-93.
  • 9. Rabsztyn A, Green PH, Berti I, Fasano A, Perman JA, Horvath K. Macroamylasemia in patients with celiac disease. Am J Gastroenterol. 2001;96:1096
  • 10. Garcia‐Gonzalez M, Defarges‐Pons V, Monescillo A, Hernandez F, Cano‐Ruiz A. Macrolipasemia and celiac disease. Am J Gastroenterol. 1995;90:2233-4.
Yıl 2021, Cilt: 3 Sayı: 2, 80 - 84, 29.04.2021
https://doi.org/10.46310/tjim.814732

Öz

Proje Numarası

-

Kaynakça

  • 1. Frulloni L, Patrizi F, Bernardoni L, Cavallini G. Pancreatic hyperenzymemia: Clinical significance and diagnostic approach.JOP. 2005 ;6:536-51.
  • 2. Holmes GK. Non-malignant complications of coeliac disease. Acta Paediatr Suppl. 1996;412:68-75.
  • 3. Carroccio A, Di Prima L, Scalici C, Soresi M, CefalÙ AB, Noto D, et al. Unexplained elevated serum pancreatic enzymes: A reason to suspect celiac disease. Clin Gastroenterol Hepatol. 2006;4:455–9.
  • 4. Hameed AM, Lam VWT, Pleass HC. Significant elevations of serum lipase not caused by pancreatitis: A systematic review. Hpb. 2015;17:99–112.
  • 5. Migliori M, Galassi E, Gullo L. Search for celiac disease in subjects with asymptomatic pancreatic hyperenzymemia. Pancreas. 2011;40:979-81.
  • 6. Freeman HJ. Celiac-associated pancreatic disease. Ann Gastroenterol. 2016;29:241-2.
  • 7. Lauret E, Rodrigo L. Celiac disease and autoimmune-associated conditions. Biomed Res Int. 2013;2013:127589
  • 8. Di Sabatino A, Corazza GR. Coeliac disease. Lancet. 2009;373:1480-93.
  • 9. Rabsztyn A, Green PH, Berti I, Fasano A, Perman JA, Horvath K. Macroamylasemia in patients with celiac disease. Am J Gastroenterol. 2001;96:1096
  • 10. Garcia‐Gonzalez M, Defarges‐Pons V, Monescillo A, Hernandez F, Cano‐Ruiz A. Macrolipasemia and celiac disease. Am J Gastroenterol. 1995;90:2233-4.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular İç Hastalıkları
Bölüm Case Reports
Yazarlar

Ahmet Bilgehan Şahin 0000-0002-7846-0870

Fazıl Hunutlu Bu kişi benim 0000-0002-4991-9830

Nesrin Uğraş Bu kişi benim 0000-0003-0127-548X

Macit Gülten 0000-0002-4186-0731

Proje Numarası -
Yayımlanma Tarihi 29 Nisan 2021
Gönderilme Tarihi 22 Ekim 2020
Kabul Tarihi 14 Ocak 2021
Yayımlandığı Sayı Yıl 2021 Cilt: 3 Sayı: 2

Kaynak Göster

EndNote Şahin AB, Hunutlu F, Uğraş N, Gülten M (01 Nisan 2021) Markedly elevated lipase as the first manifestation of celiac disease: Case Report. Turkish Journal of Internal Medicine 3 2 80–84.

e-ISSN: 2687-4245 

Turkish Journal of Internal Medicine, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png
2023 -TJIM.org